India Blood Collection Devices Market (2025-2030)
The India Blood Collection Devices Market was valued at $199 Million in 2025 and projected to reach to $325.5 Million by 2030, representing a compound annual growth rate of 10.3%. India's blood collection devices market is poised for sustained growth through 2030, supported by expanding healthcare accessibility and rising diagnostic testing volumes.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Blood Collection Devices Market Trends and Insights
- This accelerated expansion in India reflects rising healthcare infrastructure investments, increased diagnostic testing demand, and growing awareness of safe phlebotomy practices across the country.
- India's market growth significantly outpaces the global average of 7.4%, driven by expanding hospital networks, blood bank modernization, and rising prevalence of chronic diseases requiring routine blood work. The blood collection devices sector in India is benefiting from government healthcare initiatives, private sector expansion, and improved access to diagnostic services in both urban and rural regions.
- India's growing middle class and increasing healthcare spending are fueling demand for standardized, safe blood collection equipment including needles, tubes, and safety-engineered devices.
- Between 2025 and 2030, India is expected to see heightened adoption of advanced collection technologies and stricter adherence to international safety standards, positioning the country as a key growth market within the Asia Pacific region..
Key Market Statistics
- CAGR (2025-2030) 10.3% CAGR
- Market Size, 2025 ~USD 199 Million
- Forecast, 2030 ~USD 325.5 Million
- Country India
India Blood Collection Devices Market Overview
Rapid Market Expansion :
India's blood collection devices market is growing at 10.3% CAGR, significantly outpacing the global growth rate of 7.4%, driven by expanding healthcare infrastructure and increased diagnostic testing demand across urban and semi-urban regions.
Healthcare Infrastructure Investment :
Government initiatives like Ayushman Bharat and increased public health spending are strengthening diagnostic centers and hospitals, creating substantial demand for advanced blood collection equipment and safety-engineered devices.
Safety Awareness Growth :
Rising awareness of bloodborne pathogen transmission and occupational safety among healthcare workers is driving adoption of safety-engineered needles, lancets, and collection tubes across Indian medical facilities.
Diagnostic Testing Surge :
Increasing prevalence of chronic diseases, coupled with growing preventive healthcare awareness and affordable diagnostic services, is fueling demand for blood collection devices in pathology labs and diagnostic centers nationwide.
India Blood Collection Devices Market Dynamics
- The market's 10.3% CAGR reflects structural improvements in medical infrastructure, particularly in tier-2 and tier-3 cities, alongside government healthcare initiatives.
- Increasing adoption of safety-engineered devices and international quality standards will further accelerate market penetration.
- The growing middle class and enhanced health consciousness are expected to drive consistent demand for blood collection services and associated equipment across pathology networks and hospitals..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- India's blood collection devices market is valued at USD 199.0 million in 2025 and is forecast to reach USD 325.5 million by 2030, growing at a 10.3% CAGR.
- India's market growth rate of 10.3% significantly exceeds the global CAGR of 7.4%, reflecting strong regional demand and healthcare expansion.
- Government healthcare initiatives, blood bank modernization, and rising chronic disease prevalence are primary growth drivers in India.
- India is positioned as a key growth market within Asia Pacific, driven by expanding diagnostic infrastructure and increased adoption of safety-engineered collection devices.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
India Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BLOOD BANKS | 68.2 | 73.6 | 78.8 | 84.7 | 91.5 | 99.2 | 108 | 117.9 | 8.4 |
| DIAGNOSTIC & PATHOLOGY LABS | 91.9 | 100.6 | 109.2 | 119 | 130.4 | 143.4 | 158.4 | 175.5 | 9.9 |
| HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES | 219.6 | 242.5 | 265.3 | 291.4 | 321.9 | 356.7 | 396.8 | 442.9 | 10.8 |
| OTHER END USERS | 25 | 26.9 | 28.6 | 30.6 | 32.9 | 35.5 | 38.4 | 41.7 | 7.8 |
| TOTAL | 404.6 | 443.6 | 482 | 525.7 | 576.6 | 634.8 | 701.5 | 778.1 | 10.1 |
Target Audience
- Medical Device Manufacturers : Manufacturers need India-specific market data to assess market size, growth potential, and competitive dynamics for blood collection devices, enabling product development and localization strategies tailored to Indian healthcare requirements.
- Healthcare Facility Operators : Hospital chains, diagnostic centers, and pathology labs require market insights to understand procurement trends, safety device adoption rates, and supplier landscape to optimize equipment sourcing and operational efficiency.
- Distributors & Suppliers : Medical device distributors and suppliers need India market intelligence to identify growth segments, evaluate demand forecasts, and develop distribution networks aligned with regional healthcare infrastructure expansion.
- Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities in India require validated market data, growth projections, and trend analysis to assess investment viability and portfolio companies in the blood collection devices space.
- Healthcare Policy & Government Bodies : Government health agencies and policy makers need market research to understand device adoption trends, safety compliance gaps, and infrastructure needs for informed healthcare policy development and procurement planning.
Key Companies in the India Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation (USD 199M in 2025) and verified 10.3% CAGR projections for India, enabling accurate business planning and investment decisions in the blood collection devices segment.
- Competitive Positioning Intelligence : Understand India-specific market dynamics, regional demand patterns, and competitive landscape to identify growth opportunities and develop targeted strategies for market penetration and expansion.
- Healthcare Policy & Regulatory Insights : Access analysis of India's healthcare infrastructure investments, government initiatives, and safety standards driving device adoption, helping align product offerings with regulatory requirements and market needs.
- Demand Driver Analysis : Leverage detailed insights into diagnostic testing growth, chronic disease prevalence, and safety awareness trends specific to India to forecast demand and optimize supply chain and distribution strategies.
- Investment & Expansion Planning : Use India-focused market data and 2030 forecast projections to evaluate market attractiveness, assess ROI potential, and make informed decisions on manufacturing facilities, partnerships, and market entry strategies.
Frequently asked questions
What is the current market size of blood collection devices in India?
India's blood collection devices market is valued at USD 199.0 million in 2025 and is projected to grow to USD 325.5 million by 2030.
What is the expected growth rate for India's blood collection devices market?
India's blood collection devices market is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2025 to 2030.
How does India's market growth compare to global trends?
India's market growth rate of 10.3% significantly outpaces the global CAGR of 7.4%, indicating stronger regional demand and healthcare sector expansion.
What factors are driving growth in India's blood collection devices market?
Key drivers include government healthcare initiatives, blood bank modernization, rising chronic disease prevalence, expanding hospital networks, and increased diagnostic testing demand across India.
Which regions within India are experiencing the highest demand for blood collection devices?
Both urban and rural regions in India are experiencing increased demand, with growth driven by improved healthcare access, expanding diagnostic infrastructure, and rising healthcare spending among India's growing middle class.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- China Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
